Texas Invests $50M in Psychedelic Drug Research to Treat Addiction

Key Takeaways

• Texas is spending $50 million to study ibogaine, a powerful psychedelic drug

• The goal is to treat opioid addiction, depression and brain injuries

• The hope is that research will lead to federal approval of ibogaine therapy